Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 18 / Friday, January 29, 2021 / Notices to discontinue the suspension of liquidation of all entries at that time, but to continue the suspension of liquidation of all entries between July 13, 2020 and November 9, 2020.
If the U.S. International Trade Commission ITC issues a final affirmative injury determination, we will issue a CVD order, reinstate the suspension of liquidation and require a cash deposit of estimated countervailing duties for such entries of subject merchandise in the amounts indicated above, in accordance with section 706a of the Act. If the ITC determines that material injury, or threat of material injury, does not exist, this proceeding will be terminated, and all estimated duties deposited or securities posted as a result of the suspension of liquidation will be refunded or canceled.
International Trade Commission Notification In accordance with section 705d of the Act, we will notify the ITC of our affirmative determination that countervailable subsidies are being provided to producers and exporters of corrosion inhibitors from China.
Because the final determination in this proceeding is affirmative, in accordance with section 705b of the Act, the ITC
will make its final determination as to whether the domestic industry in the United States is materially injured, or threatened with material injury, by reason of imports of corrosion inhibitors from China no later than 45 days after our final determination. If the ITC
determines that material injury or threat of material injury does not exist, this proceeding will be terminated and all cash deposits will be refunded. If the ITC determines that such injury does exist, Commerce will issue a countervailing duty order directing CBP
to assess, upon further instruction by Commerce, countervailing duties on all imports of the subject merchandise that are entered, or withdrawn from warehouse, for consumption on or after the effective date of the suspension of liquidation, as discussed above in the Continuation of Suspension of Liquidation section.

khammond on DSKJM1Z7X2PROD with NOTICES

Notification Regarding Administrative Protective Orders In the event that the ITC issues a final negative injury determination, this notice will serve as the only reminder to parties subject to an administrative protective order APO of their responsibility concerning the destruction of proprietary information disclosed under APO in accordance
VerDate Sep<11>2014

17:43 Jan 28, 2021

Jkt 253001

with 19 CFR 351.305a3. Timely written notification of the return/
destruction of APO materials or conversion to judicial protective order is hereby requested. Failure to comply with the regulations and terms of an APO is a violation which is subject to sanction.
Notification to Interested Parties This determination is issued and published pursuant to sections 705d and 777i of the Act and 19 CFR
351.210c.
Dated: January 25, 2021.
Christian Marsh, Acting Assistant Secretary for Enforcement and Compliance.

Appendix I
Scope of the Investigation The merchandise covered by this investigation is tolyltriazole and benzotriazole. This includes tolyltriazole and benzotriazole of all grades and forms, including their sodium salt forms.
Tolyltriazole is technically known as Tolyltriazole IUPAC 4,5 methyl benzotriazole. It can also be identified as 4,5
methyl benzotriazole, tolutriazole, TTA, and TTZ.
Benzotriazole is technically known as IUPAC 1,2,3-Benzotriazole. It can also be identified as 1,2,3-Benzotriazole, 1,2Aminozophenylene, lH-Benzotriazole, and BTA.
All forms of tolyltriazole and benzotriazole, including but not limited to flakes, granules, pellets, prills, needles, powder, or liquids, are included within the scope of this investigation.
The scope includes tolyltriazole/sodium tolyltriazole and benzotriazole/sodium benzotriazole that are combined or mixed with other products. For such combined products, only the tolyltriazole/sodium tolyltriazole and benzotriazole/sodium benzotriazole component is covered by the scope of this investigation. Tolyltriazole and sodium tolyltriazole that have been combined with other products is included within the scope, regardless of whether the combining occurs in third countries.
Tolyltriazole, sodium tolyltriazole, benzotriazole and sodium benzotriazole that is otherwise subject to this investigation is not excluded when commingled with tolyltriazole, sodium tolyltriazole, benzotriazole, or sodium benzotriazole from sources not subject to this investigation. Only the subject merchandise component of such commingled products is covered by the scope of this investigation.
A combination or mixture is excluded from this investigation if the total tolyltriazole or benzotriazole component of the combination or mixture regardless of the source or sources comprises less than 5 percent of the combination or mixture, on a dry weight basis.

PO 00000

Frm 00014

Fmt 4703

Sfmt 4703

7539

Notwithstanding the foregoing language, a tolyltriazole or benzotriazole combination or mixture that is transformed through a chemical reaction into another product, such that, for example, the tolyltriazole or benzotriazole can no longer be separated from the other products through a distillation or other process is excluded from this investigation.
Tolyltriazole has the Chemical Abstracts Service CAS registry number 299385431.
Tolyltriazole is classified under Harmonized Tariff Schedule of the United States HTSUS
subheading 2933.99.8220.
Sodium Tolyltriazole has the CAS registry number 64665572 and is classified under HTSUS subheading 2933.99.8290.
Benzotriazole has the CAS registry number 95147 and is classified under HTSUS
subheading 2933.99.8210.
Sodium Benzotriazole has the CAS registry number 15217422. Sodium Benzotriazole is classified under HTSUS subheading 2933.99.8290.
Although the HTSUS subheadings and CAS registry numbers are provided for convenience and customs purposes, the written description of the scope of this investigation is dispositive.

Appendix II
List of Topics Discussed in the Issues and Decision Memorandum I. Summary II. Background III. Subsidies Valuation IV. Use of Facts Otherwise Available and Adverse Inferences V. Analysis of Programs VI. Analysis of Comments Comment 1: Whether Commerce Should Reconsider the Petitioners Standing to Bring the Investigation Comment 2: Whether Commerce Should Renew Suspension of Liquidation and Collection of Cash Deposits Prior to the Publication of an Affirmative Determination by the ITC
Comment 3: Countervailability of the Export Buyers Credit Program Comment 4: Whether Commerce Should Select a Different Benchmark for the Provision of Land-Use Rights for Less Than Adequate Remuneration LTAR
for Encouraged Industries Comment 5: Countervailability of the Provision of Electricity for LTAR
Comment 6: Whether the Provision of Ortho Phenylene Diamine for LTAR is Specific Comment 7: Benchmarks for the Calculation of Inputs for LTAR
Comment 8: Countervailability of Other Subsidies VII. Recommendation FR Doc. 202101976 Filed 12821; 8:45 am BILLING CODE 3510DSP

E:FRFM29JAN1.SGM

29JAN1